Optical imaging developer DOBI Medical International has received clearance by the Russian Federal Service of Health Care and Social Development Control for the use of its ComfortScan system in connection with the diagnosis of breast cancer.
The approval runs for a 10-year period through April 2016, according to the Mahwah, NJ-based vendor.
By AuntMinnie.com staff writers
April 17, 2006
Related Reading
DOBI seeks to update clinical trials, February 2, 2006
DOBI releases ComfortScan 2.0 software, January 19, 2006
Road to RSNA, DOBI Medical International, November 7, 2005
DOBI signs Beardsworth for PMA trial, November 3, 2005
DOBI reveals China strategy, October 25, 2005
Copyright © 2006 AuntMinnie.com
